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Abstract: Malnutrition is prevalent in patients with head and neck cancer (HNC), impacting
outcomes. Despite publication of nutrition care evidence-based guidelines (EBGs), evidence–practice
gaps exist. This study aimed to implement and evaluate the integration of a patient-centred,
best-practice dietetic model of care into an HNC multidisciplinary team (MDT) to minimise the
detrimental sequelae of malnutrition. A mixed-methods, pre–post study design was used to deliver
key interventions underpinned by evidence-based implementation strategies to address identified
barriers and facilitators to change at individual, team and system levels. A data audit of medical
records established baseline adherence to EBGs and clinical parameters prior to implementation
in a prospective cohort. Key interventions included a weekly Supportive Care-Led Pre-Treatment
Clinic and a Nutrition Care Dashboard highlighting nutrition outcome data integrated into MDT
meetings. Focus groups provided team-level evaluation of the new model of care. Economic
analysis determined system-level impact. The baseline clinical audit (n = 98) revealed barriers
including reactive nutrition care, lack of familiarity with EBGs or awareness of intensive nutrition
care needs as well as infrastructure and dietetic resource limitations. Post-implementation data
(n = 34) demonstrated improved process and clinical outcomes: pre-treatment dietitian assessment;
use of a validated nutrition assessment tool before, during and after treatment. Patients receiving the
new model of care were significantly more likely to complete prescribed radiotherapy and systemic
therapy. Differences in mean percentage weight change were clinically relevant. At the system
level, the new model of care avoided 3.92 unplanned admissions and related costs of $AUD121K per
annum. Focus groups confirmed clear support at the multidisciplinary team level for continuing the
new model of care. Implementing an evidence-based nutrition model of care in patients with HNC
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is feasible and can improve outcomes. Benefits of this model of care may be transferrable to other
patient groups within cancer settings.
Keywords: head and neck neoplasms; malnutrition; implementation; evidence-based practice;
research translation
1. Introduction
Malnutrition is prevalent in patients with head and neck cancer (HNC) with rates commonly
reported between 30% and 50% [1]. Causes and consequences of malnutrition are multifactorial,
impacting on a range of outcomes including clinical, cost and patient-centred measures for which
relevant evidence is summarized in international oncology nutrition evidence-based guidelines
(EBGs) [2–6]. As treatment for HNC has deleterious effects on organs essential for normal human
functions such as eating, drinking, breathing and speaking, patients with HNC and their caregivers are
among the highest in need in terms of their experience of disease and treatment burden, requiring
access to well-coordinated multidisciplinary team (MDT) care before, during and after treatment [7,8].
In 2011, internationally-endorsed comprehensive EBGs for nutritional management of adult patients
with HNC [9] were developed via systematic review and disseminated online via a web-based wiki
platform [10]. However, evidence–practice gaps persist [11,12].
The HNC EBGs were developed according to recognised evidence synthesis methods [13,14] and
the Nutrition Care Model [15,16], comprised of three domains: Appropriate Access to Care (Nutrition
Screening, Nutrition Assessment); Quality Nutrition Care (Goals, Prescription, Implementation);
and Nutrition Evaluation and Monitoring (Measure and Evaluate Outcomes). The best available
evidence supports key recommendations for early and ongoing access to specialist oncology dietitians
with expertise in complex cancer nutrition care needs, but adequate dietetic resources to deliver
optimum care are frequently scarce [9,11,17–20].
Implementation of research evidence into routine clinical care is a well-recognised challenge and
the focus of considerable health service research efforts in order to understand barriers to change and
the most effective implementation strategies to overcome them [21]. Potential benefits of EBGs can only
be realized upon successful implementation. Hence, systematic reviews highlight a range of influencing
factors that require consideration in order for clinical care to align with EBG recommendations. These
include complexity of the guidelines, lack of awareness or familiarity with the guidelines, lack of
support at the organizational level and limitations in time and resources [22,23]. Implementation
science literature broadly advocates for a multistrategic approach in order to improve adherence to
EBGs in clinical practice [22,24].
To date, one Australian study has reported on the successful delivery of a dietitian-led behavior
change intervention to increase adherence to the HNC EBGs, demonstrating improvements in
nutritional status, quality of life and treatment completion [25–27]. Few other published studies
have taken a multistrategic, patient-centred approach to implementing best-practice nutrition care
for patients with HNC addressing barriers and facilitators at the individual, team and system levels
which are then tested in a real-world setting. The aim of the present study was to: (i) determine the
feasibility of implementing an evidence-based model of care for nutritional management of adult
patients with HNC and; (ii) explore the subsequent impact of the new model of care on individual-,
team- and system-level outcomes. Through integration with the MDT, the model of care aimed to
take a patient-centred approach to delivery of nutritional care to minimise the detrimental sequelae of
malnutrition and improve outcomes in this complex patient group.
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2. Materials and Methods
2.1. Context and Study Design
A mixed-methods, pre–post study design was employed to evaluate outcomes of interest both
prior to, and following, implementation of a pilot evidence-based model of nutrition care in an
Australian tertiary referral HNC unit. The 24 month project consisted of three phases covering
pre-implementation (ten months), implementation (eight months) and analysis (six months). As the
aim was to determine feasibility of delivering an evidence-based model of care, the eight month
intervention phase was deemed a suitable timeframe. A clinical audit of medical records established
adherence to the EBG recommendations and impact on quantitative outcomes. Exploration of barriers
and facilitators to delivery of best-practice nutrition care at individual, team and system levels occurred
via prior consultation with patients, caregivers [28] and clinicians. Post-implementation, team-level
evaluation of the model of care involved focus groups with MDT members. This paper presents the
results of the clinical audit and post-implementation MDT focus groups.
2.2. Study Population
In the pre-implementation and post-implementation phases, adult patients (≥18 years) undergoing
radiotherapy +/− other treatment modality of curative intent for HNC were identified via the weekly
MDT meeting lists.
In the post-implementation phase, focus groups with members of the HNC MDT including
medical (radiation/medical oncologists, surgeons) and specialist nursing and allied health professionals
(dietitians, speech pathologists, psychologists and radiation therapists) were conducted.
2.3. Interventions
The pilot model of care incorporated the introduction of two key interventions as agreed to by the
MDT as part of a priority setting workshop on presentation of the baseline qualitative and quantitative
exploratory data collected via a retrospective clinical audit and semi-structured interviews with
stakeholders. The following two interventions were ultimately chosen through reaching consensus on
discussion with the MDT:
2.3.1. The Supportive Care-Led Pre-Treatment Clinic
The Supportive Care-Led Pre-Treatment Clinic comprised a dedicated clinic resourced by advanced
practice clinicians, specifically, a senior specialist dietitian and clinical nurse consultant to deliver
structured, targeted pre-treatment assessment, intervention, education and counselling to patients and
caregivers. Service structures and processes were re-organized, enabling specialist staff to deliver care
aligned with EBG recommendations. Routine nursing care already provided pre-treatment assessment
on an ad-hoc basis, and hence only additional senior dietetic staffing funded by the research grant was
required for the pilot.
2.3.2. Nutrition Care Dashboard
The Nutrition Care Dashboard served to highlight nutrition care processes and clinical outcomes
and was integrated into the existing HNC Radiation Oncology list for discussion at the weekly MDT
meetings. The Nutrition Care Dashboard was nominated by the MDT as a preferred intervention and
was phased into meetings over several weeks through an iterative co-design process [29] to incorporate
feedback from members. A key design element included a traffic light color-coded flagging system to
highlight the change from baseline in both degree of critical weight loss (<5%, ≥5 to <10% and ≥10%)
and nutritional status as defined by the Scored Patient-Generated Subjective Global Assessment (Scored
PG-SGA) [30,31] denoting those patients who were well nourished (A), moderately malnourished (B)
or severely malnourished (C). In addition, any escalation in nutrition-impact symptoms represented by
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the scored component of this nutrition assessment tool, validated for use in the oncology population,
was also flagged.
2.4. Implementation Strategies
A detailed implementation plan underpinned by a recognised implementation framework [32]
supported the intervention phase of this study, which included the following: clinical practice change
strategies, MDT engagement, integrated care, information technology strategies, audit and feedback,
staff education and support, and opinion leaders.
2.4.1. Clinical Practice Change Strategies
A range of clinical practice change strategies was employed to support the systematic uptake
of the EBG recommendations. These included the development of an evidence-based nutrition care
pathway with clearly defined screening and assessment protocols, timing and frequency of dietetic
contact before, during and after treatment and routine use of validated malnutrition screening and
nutrition assessment tools. Dietitians were provided with education and support regarding use of
the PG-SGA tool to ensure confidence in utilising this assessment regularly and to encourage weekly
reporting of nutrition outcomes via the Nutrition Care Dashboard for discussion at the weekly MDT.
2.4.2. Multidisciplinary Team Engagement
During all phases of this study, MDT members were consulted through a series of meetings with
resulting feedback incorporated into the pilot model of care. Input was actively sought to co-design
evidence-based nutrition care pathways and electronic clinical documentation templates, participation
in relevant priority setting and education workshops, interviews and focus groups and ultimately to
deliver and evaluate the model of care.
2.4.3. Integrated Care
The new model of care specifically targeted key opportunities within existing care pathways and
processes to facilitate uptake of the guidelines.
2.4.4. Information Technology—Dietitian-Specific Clinical Documents in the Electronic
Medical Record
A suite of dietitian-specific clinical documentation templates with extractable data fields were
created in the electronic medical record (eMR) to replace the free text-only documents historically
available and support future sustainability through digital automation of the Nutrition Care Dashboard.
As handover of clinical care occurs frequently between dietitians and care settings throughout the
trajectory of patient care, the availability of standardized nutrition care information serves to enhance
communication and continuity of care between clinicians and care settings.
2.4.5. Audit and Feedback
The Nutrition Care Dashboard fulfilled the dual role of communicating timely clinical nutrition
outcome information broadly to the MDT but also provided the function of ongoing weekly audit and
feedback through highlighting whether adherence to agreed benchmarks were being met.
2.4.6. Staff Education and Support
Dietitians responsible for the nutrition care of patients with HNC received practical training in
administering the Scored PG-SGA and were asked to evaluate their degree of confidence in utilising
the tool before and after the training session. Staff were trained in documenting in the newly created
dietitian-specific clinical documents in the eMR.
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2.4.7. Opinion Leaders
Senior leaders within the participating cancer centre organization were invited to join the team
of investigators. Their dual roles as clinical leads within the HNC MDT and also executive opinion
leaders served to ensure organizational support and endorsement of the implementation program.
2.5. Clinical Audit Outcomes
The primary outcome in this study was the adherence to EBG nutrition care processes presented
in Table 1. Adherence criteria were defined as the proportion of patients who received nutrition care
in accordance with evidence-based recommendations throughout the trajectory of care. Evaluation
of practice change regarding uptake of recommendations to apply validated nutrition assessment
tools required a dietetic consult. The clinical audit conducted by the investigator team facilitated
assessment of care delivery compared to the best available evidence. Secondary clinical outcomes
included weight change (%) (calculated as difference in recorded weight (kg) between initial dietitian
assessment and final week of radiotherapy), Body Mass Index (BMI, kg/m2) and whether radiotherapy
and systemic therapy protocols were delivered as planned. System-level impact was examined via
unplanned hospital admissions and dietetic resources required to deliver nutrition care. An economic
analysis examined the financial implications of delivering the new model of care. Nutrition risks were
captured for each patient on clinic attendance and these were categorized according to a recognised
national health care quality and patient safety risk matrix [33]. Nutrition risk categorization and
severity of potential incidents avoided was further verified with the organizational patient safety and
quality manager.
2.6. Team-Level Outcomes—Multidisciplinary Team Focus Groups
Process evaluation of the model of care was undertaken according to Proctor et al.’s implementation
outcomes framework [34]. MDT members were invited and consented to participate in focus groups
held for each of the following disciplines: allied health and nursing professionals, oncologists,
and surgeons. To ensure a group perspective was obtained [35], three semi-structured focus groups
were facilitated by a study investigator (N.R.) not involved in the delivery of clinical care or the
implementation strategies. The face-to-face focus groups were conducted based on a semi-structured
schedule covering the same topics for each group (Supplementary Table S1). Focus groups were
recorded, transcribed verbatim and thematically analysed. Two members of the research team
(M.F. and N.R.) each reviewed three transcripts independently prior to meeting. Using an inductive,
thematic approach, a coding framework was derived from descriptive phrases by research team
members (M.F. and N.R.) who then completed coding of the transcripts. Themes were established
using an iterative approach, with supporting quotations identified and extracted.
2.7. System-Level Outcomes
Economic consequences of the new model of care were evaluated from an organizational
perspective. For pre-implementation unplanned admissions, cost data were obtained from the hospital
performance unit and are reported as the mean cost per episode in Australian dollars ($AUD).
The economic analysis accounted for both direct clinical care and required associated administrative
time and assumed no displacement for infrastructure or staffing resources. The latter was calculated
according to the current state health professional’s award [36], inclusive of 15% on-costs.
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Table 1. Evidence-based guideline recommendations and adherence criteria.





•Malnutrition screening should be undertaken on all patients at
diagnosis to identify nutritional risk and then repeated at intervals
through each stage of treatment (e.g., surgery, radio/chemotherapy
and post-treatment).
B • Screening using the MST b occurred before Week 1 of radiotherapy.
• All patients receiving radiotherapy to the head and neck should be
referred to the dietitian for nutrition support. B • Dietetic consult occurred before Week 1 of radiotherapy.
• Use a validated nutrition screening tool (e.g., MST) for identifying
malnutrition risk. B • Use of the MST occurred before Week 1 of radiotherapy.
• Use a validated nutrition assessment tool (e.g., PG-SGA c). B • Use of PG-SGA occurred when assessing nutritional status.
Quality Nutrition Care •Weekly dietitian contact improves outcomes in patients receivingradiotherapy. A
• Dietetic consult occurred for every five fractions of radiotherapy
given in a single working week period.
Nutrition Monitoring and
Evaluation
• Patients should be seen weekly by a dietitian during radiotherapy. A • As above.
• Patients should receive minimum fortnightly follow up by a
dietitian for at least 6 weeks post-treatment. A
• Dietetic consult occurred at least once in a 14 day period following
end of radiotherapy for three consecutive fortnights.
•Monitor weight, intake and nutritional status during and
post-(chemo)radiotherapy. A
• Use of Scored PG-SGA occurred at baseline, mid-RT d (Week 3–4),
end-RT (Week 6–7) and at post-RT dietitian consults.
a NHMRC = National Health and Medical Research Council; b MST = Malnutrition Screening Tool; c PG-SGA = Patient-Generated Subjective Global Assessment; d RT = radiotherapy.
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2.8. Data Collection
Data were collected from hospital electronic and paper-based medical records and managed using
Research Electronic Data Capture (REDCap) tools hosted at Sydney Local Health District [37].
2.9. Statistical Analysis
Participant baseline characteristics are reported using mean and standard deviation (SD) for
continuous variables and frequency and percentage for categorical variables. Distributions of
continuous variables were checked for normality and variance using the Shapiro–Wilk test and Levene’s
test respectively. Normally distributed variables underwent parametric analyses while non-normally
distributed data were analysed using non-parametric methods or underwent transformation to
normalize data distribution. Differences in continuous variables collected pre- and post-implementation
were determined via independent group t-tests or the Mann–Whitney U test, while categorical variables
were analysed with Chi-squared tests. Analysis was completed using SPSS version 25 (SPSS, Chicago,
IL, USA).
2.10. Ethics Approval and Reporting
Ethics approval was obtained from the Human Research Ethics Committee at Royal Prince
Alfred Hospital, Sydney, Australia (HREC/14/RPAH/524) with site-specific approval for this study
to be conducted at Royal Prince Alfred Hospital (SSA/15/RPAH/148) and Chris O’Brien Lifehouse




For the pre-implementation phase, a randomly selected sample of patients who commenced
treatment within a two-year period (January 2013–December 2014) yielded a retrospective cohort of
100 patients who had received current standard nutrition care. One patient did not meet the inclusion
criteria and one patient died prior to commencing treatment and were withdrawn from this study,
yielding a final pre-implementation cohort of (n = 98). The implementation phase (October 2016 to
May 2017) delivered the new model of care to a pilot cohort (n = 34). Patient demographics, diagnosis,
treatment characteristics and baseline nutrition measures are summarized in Table 2. There were
no differences between baseline characteristics with the exception of nutritional status, with more
patients assessed as malnourished (SGA Category B/C) in the post-implementation group (n = 16, 48%)
compared to those that received pre-implementation standard care (n = 12, 16%), (p < 0.001).
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Table 2. Comparison of clinical characteristics between pre- and post-implementation cohorts.
Characteristic
Pre-Implementation (N = 98) Post-Implementation (N = 34)
p Value *
N (%) N (%)
Age, Years 0.394 **
Mean (SD) 61.8 (12.3) 63.8 (10.4)
Gender 0.281
Male 75 (77) 29 (85)
Female 23 (23) 5 (15)
Disease Stage 0.935
I 2 (2) 1 (3)
II 12 (14) 3 (10)
III 17 (20) 7 (24)
IV 55 (64) 18 (62)
Tumour Site 0.719
Oral cavity/lip 18 (18) 6 (18)
Oropharynx 36 (37) 18 (53)
Hypopharynx 3 (3) 1 (3)
Larynx 13 (13) 4 (12)
Nasopharynx 15 (15) 1 (3)
Nasal/paranasal sinus 3 (3) 1 (3)
Salivary gland 7 (7) 2 (6)
Other/unknown primary 3 (3) 1 (3)
Tumour Type 0.117
Squamous cell carcinoma 86 (88) 33 (97)
Other 12 (12) 1 (3)
Treatment Modality 0.361
RT a—definitive 15 (15) 9 (26)
CRT b—definitive 43 (44) 16 (47)
Surgery + CRT—adjuvant 8 (8) 2 (6)
Surgery + RT—adjuvant 32 (33) 7 (21)
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Table 2. Cont.
Characteristic
Pre-Implementation (N = 98) Post-Implementation (N = 34)
p Value *
N (%) N (%)
Performance Status 0.310
ECOG c 0 41 (42) 17 (50)
ECOG 1 32 (33) 14 (41)
ECOG 2 6 (6) 0 (0)
ECOG 3 1 (1) 0 (0)
ECOG 4 0 (0) 0 (0)
Not documented 18 (18) 3 (9)
Tobacco Use 0.143
No 33 (34) 15 (44)
Yes 56 (57) 19 (56)
Not documented 9 (9) 0 (0)
Smoking Status 0.133
Never smoked 0 (0) 0 (0)
Current smoker 19 (34) 3 (16)
Previous smoker 37 (66) 16 (84)
Alcohol Use 0.096
None or social only 49 (50) 21 (62)
1–2 standard drinks/d 8 (8) 2 (6)
>2 standard drinks/d 26 (27) 11 (32)
Not documented 15 (15) 0 (0)
HPV d Status 0.059
Negative 4 (4) 5 (15)
Positive 17 (17) 8 (24)
Not documented 77 (79) 21 (62)
Nutrition Support Delivery Mode 0.852
Gastrostomy—PEG e 37 (54) 10 (50)
Gastrostomy—RIG f 13 (19) 4 (20)
Gastrostomy—surgical 2 (3) 0 (0)
NGT g 15 (22) 6 (30)
TPN h 1 (1) 0 (0)
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Table 2. Cont.
Characteristic
Pre-Implementation (N = 98) Post-Implementation (N = 34)
p Value *
N (%) N (%)
Height, cm 0.768 **
Mean (SD) 171.5 (8.5) 172.0 (9.1)
Weight, kg 0.954 **
Mean (SD) 75.6 (23.0) 75.3 (19.4)
BMI i, kg/m2 0.824 **
Mean (SD) 25.5 (7.1) 25.2 (5.4)
Nutritional Status, PG-SGA j Score <0.001 **
Mean (SD) 4.4 (5.6) 8.7 (4.5)
Nutritional Status, PG-SGA Category <0.001
A (well nourished) 63 (84) 17 (52)
B (moderately malnourished) 8 (11) 13 (39)
C (severely malnourished) 4 (5) 3 (9)
a RT = radiotherapy; b CRT = chemoradiotherapy; c ECOG = European Co-Operative Group; d HPV = Human Papilloma Virus; e PEG = Percutaneous Endoscopic Gastrostomy;
f RIG = Radiologically Inserted Gastrostomy; g NGT = Nasogastric Tube; h TPN = Total Parenteral Nutrition; i BMI = Body Mass Index; j PG-SGA = Patient-Generated Subjective Global
Assessment; * χ2 of independence; ** t-test.
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3.2. Adherence to Evidence-Based Guideline Recommendations
The proportion of patients that received nutrition care according to the EBG recommendations
is reported for the pre-implementation and post-implementation phases in Table 3. For the domain
of Appropriate Access to Care (Screening and Assessment), use of validated tools was improved for
malnutrition screening 14% (n = 14 of 98) to 88% (n = 30 of 34; p < 0.001) and nutritional assessment
(pre-treatment, p = 0.018 and all other time points, p < 0.001). Adherence to the evidence-based
Dietitian Appointment Schedule was most improved at the pre-treatment time point, coinciding with
the targeted Supportive Care-Led Pre-Treatment Clinic intervention, where early access to dietetic
assessment and intervention increased from 20% (n = 20 of 98) to 97% (n = 33 of 34; p < 0.001).
One patient was not offered a pre-treatment appointment as they had been unintentionally omitted
from the weekly MDT list, the primary source of identifying new patients, and hence dietetic referral
was not triggered. There was no improvement in adherence to the recommendation for weekly dietitian
review during treatment (52% versus 59%, p = 0.275) or fortnightly dietetic review post-treatment
(12% both groups).
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Table 3. Summary of key results—comparison of outcome measures between pre- and post-implementation cohorts.
Outcome Measure/NHMRC a Grade of Recommendation
Pre-Implementation (N = 98) Post-Implementation (N = 34)
p Value *
N (%) N (%)
Process
Nutrition screening (Grade B) <0.001 **
Screened with validated tool 14 (14) 30 (88)
Nutritional assessment (Grade B)
Nutritional assessment with validated tool on dietitian review
- pre-treatment 73 (85) 33 of 33 (100) 0.018 **
- during treatment 3 (3) 26 of 34 (79) <0.001 **
- end treatment 5 (6) 15 of 34 (54) <0.001 **
- post-treatment (T1) 2 (3) 22 of 29 (73) <0.001 **
- post-treatment (T2) 3 (6) 14 of 20 (67) <0.001 **
- post-treatment (T3) 3 (9) 10 of 17 (59) <0.001 **
Dietitian Appointment Schedule (Grade A)
Received recommended dietitian assessment
- pre-treatment 20 (20) 33 (97) <0.001 **
- weekly during treatment 47 (48) 20 (59) 0.275 **
- fortnightly for 6 weeks post-treatment 12 (12) 4 (12) 0.864 **
Clinical
Radiotherapy delivered as planned 0.041
No 11 (11) 0 (0)
Yes 87 (89) 34 (100)
Systemic therapy delivered as planned 0.005
No 17 (33) 0 (0)
Yes 34 (67) 18 (100)
Weight change during treatment, % 0.432 **
Mean (SD) −5.9 (4.2) −4.6 (5.3)
BMI b post-treatment, kg/m2 0.989 **
- Mean (SD) 24.3 (5.6) 24.3 (4.1)
System
Dietitian resources—occasions of service 0.613 **
Mean (SD) 13.1 (9.8) 14.1 (7.1)
Unplanned admission 0.499
No 54 (55) 21 (62)
Yes 44 (45) 13 (38)
Unplanned admission—reason 0.067
Treatment toxicity—nutrition/hydration 20 (45) 3 (23)
Treatment toxicity—other 14 (32) 7 (54)
Social circumstances 3 (7) 3 (23)
Other 7 (16) 0 (0)
a NHMRC = National Health and Medical Research Council; b BMI—Body Mass Index; * χ2 of independence; ** t-test.
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3.3. Nutrition Outcomes
There were no statistically significant differences in BMI or mean weight change (%) between the
two groups over the course of care. However, mean weight change remained below the clinically
important poor prognostic threshold of ≥5% at all but one time point (−5.1% at week 6 RT) for patients
who received the new model of care compared to the pre-implementation group in which progressive
post-treatment weight loss was observed at post-treatment time points 1 (−6.3%), 2 (−7.5%) and
3 (−7.5%). Nutrition-related risks were identified in 74% of patients (n = 25 of 34) at presentation to the
Supportive Care-Led Pre-Treatment Clinic with a median (range) of 1 (0–3) nutrition-related risk per
patient (total 43 risks). These risks included malnutrition (47%), social isolation or financial hardship,
suggesting either limited support and potential food and nutrition insecurity (29%), declining a clinically
indicated feeding tube (9%), following an alternative, unproven diet or clinically contraindicated
nutritional supplement regimen (9%), aspiration (3%) and high risk of refeeding syndrome (3%).
All nutrition-related risks were categorized as potential ‘medium’ risk according to the organizational
risk management framework.
3.4. Treatment Completion
The proportion of patients for whom radiotherapy dose was delivered as planned in the
pre-implementation cohort was 89% (n = 89 of 98) versus 100% (n = 34 of 34) in the post-implementation
cohort, (p = 0.041). Patients offered the new model of care were more likely to receive systemic therapy
dose as prescribed, 67% (n = 34 of 51) versus 100% (n = 18) (p = 0.005). Reasons for change in
treatment protocols in the pre-implementation group observed for radiotherapy were: treatment
toxicity (nutrition and hydration) (2/11, 18%); treatment toxicity (other, e.g., skin reaction) (3/11, 27%);
patient deterioration (1/11, 9%); other (2/11, 18%); not documented (3/11, 27%). Change in treatment
protocol for chemotherapy was attributable to treatment toxicity (nutrition and hydration) (1/17, 6%)
and treatment toxicity (other, e.g., myelosuppression, ototoxicity) (16/17, 94%).
3.5. Unplanned Admission, Economic Analysis and Dietetic Resources
There was a 15% relative (7% absolute) reduction (p = 0.499) in unplanned admission rates between
the pre- and post-implementation groups. Reasons for unplanned admissions were not significantly
different between groups, but a trend toward reduction in nutrition and hydration-related unplanned
admissions was observed (20/44, 45% versus 3/13, 23%, p = 0.067) (Table 3). The mean cost of unplanned
admissions in the pre-implementation cohort was $AUD30,897/episode. At the system level, the new
model of care avoided a projected annualized 3.92 unplanned admissions and related expenses of
$AUD121,100/annum. In terms of dietetic occasions of service (OOS), the new model of care did
not require more dietetic resources to deliver (p = 0.613). Patients who required unplanned hospital
admission utilised more dietetic resources compared to those who were not admitted over the course
of care (median (range) OOS 15 (3–66) versus 8 (2–29), p < 0.001). Taking into account the investment
required to resource a senior dietitian to deliver the new model of care, there remained a cost reduction
of $AUD14.65 for every dollar spent on delivering the new model of care.
3.6. Fidelity
Fidelity was monitored to ensure the intervention was delivered as planned during the study
period between October 2016 and May 2017. For the Supportive Care-Led Pre-Treatment Clinic,
97% (n = 33 of 34) of eligible patients were offered a clinic appointment and 100% of these attended.
For the Nutrition Care Dashboard integrated into the weekly radiotherapy list, discussion occurred as
intended at 100% of MDT meetings during the intervention period whilst the MDT clinical year was
in session.
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3.7. Contextual Changes
Substantial organizational change occurred between the pre-implementation and
post-implementation study phases. During the study period, cancer services within which the head
and neck oncology unit sits transitioned from a large public hospital to a public–private partnership
model of service delivery. While treatment services remained largely unchanged, challenges arose with
the introduction of separate allied health staff designated for public and privately insured patients.
Every effort was made to take an inclusive approach to the range of participating clinicians providing
care to patients with HNC regardless of employing organization. While it was not possible to control
for the scale of organizational change, the authors acknowledge that this occurred during the study
period and believe this to be reflective of conducting implementation research in a real-world setting
and that the flexibility and adaptability of the research team ensured any issues that arose were largely
able to be addressed.
3.8. Harms
No harms were identified as a result of the implementation. Conversely, as presented elsewhere
in this paper, the new model of care facilitated early identification of a range of nutrition risks that were
addressed sooner, potentially minimising the risk of any nutrition-related harm to patients during
their cancer care.
3.9. Implementation of Team-Level Evaluation—Multidisciplinary Focus Groups
MDT members (n = 12) participated in a series of three focus groups with allied health (n = 5),
medical (n = 5) and nursing (n = 2) disciplines represented, confirming clear support for continuing
the new model of care. The key themes identified and supporting quotations are presented in Table 4.
To preserve participant anonymity, allied health professional and nursing discipline responses are
reported as “Supportive Care Clinician” with oncologists and surgeons reported as “Medical Clinician.”
Table 4. Qualitative analysis—key themes identified through focus groups with head and neck oncology
multidisciplinary team members (N = 12).




“ . . . that list (Nutrition Care Dashboard) works like our bible in terms of who’s on treatment, where
they’re at and what’s going on.”
Supportive Care Clinician 6
“My clinic on the Monday morning now runs on time, because I don’t spend an hour and a quarter




“Well we definitely have a structure to the MDT. I do not think the structure extends well beyond
surgery and radiation therapy. I think that leadership outside of that should be allocated, because at
the moment it is really just assumed . . . I think that it would be very beneficial for us to have a
well-established structure, as to how the service is run, who answers to whom, and who is control of
what. I think a lot of it is assumed and really should be actually spelt out.”
Medical Clinician 5
“There needs to be a driver. A champion . . . and someone to be present at the MDT because the list
comes up and the doctors look around, and it’s like someone needs to start talking.”
Supportive Care Clinician 1
Value of Nutrition
Care
“We are less likely to lose people. But what the intangible is that the intake - what I call intake - the
pre-therapy assessment forces the multidisciplinary team, particularly the surgeons, to stop and think
about the radiotherapy.”
Medical Clinician 3
“And it’s (nutrition care) not really my expertise, so as a dietitian, I would do a worse job and cost
more to do it.”
Medical Clinician 3
“I think there are two aspects that struck me, which were it’s useful to know what the effect of the
surgery has been, going into radiation therapy...So to see the percentage body weight loss was
educational. It is also useful to have a comparison . . . because as surgeons we do not really know
what the typical nutritional effects of radiation therapy are. We have our assumptions and biases but
we do not really have any objective evidence.”
Medical Clinician 4
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“Well, so it’s a set formal structured clinic where patients are seen pre-radiotherapy and it’s at a time
set aside with the nurse and the dietitian and the patient attends that sole appointment . . . Whereas
prior to that, I would have to try and catch them which was very haphazard and I don’t believe that
the patients were concentrating on our consult or our education. This (Nutrition Care Dashboard) is
like a checklist now, it’s an assurance that patients are educated particularly those having a
gastrostomy tube at a point in time prior to treatment where they can absorb the information. If they
don’t understand the information they can contact us...So, it’s a thorough process– I’ve set aside time
now in my weekly routine that I attend this clinic on a Wednesday morning. Rather than I’ll go
Monday, I’ll go Tuesday I’ll go and try and find them here. It is much easier - structured I guess, for
patients and for me.”
Supportive Care Clinician 7
“And it’s (the Nutrition Care Dashboard) a visual support tool . . . as a team to say, “This is why we
need such a strong Allied Health team because look at all the patients that you’re looking after. It’s not
just you’re on treatment, see you later. It’s an ongoing care.”
Supportive Care Clinician 4
Prepared for Care
“The pre-treatment clinic provides them (patients and caregivers) the information and the dedicated
environment which is not the same as when they’re getting told about their radiation and their
diagnosis . . . .”
Medical Clinician 1
“ . . . something I am no longer surprised when I’m asked - when a patient needs admission during
radiotherapy because now we usually we see it coming.”
Medical Clinician 3
“I would say, at the moment, it feels really good that patients know what they’re doing, where they’re
going, not all new and scary information when I’m first seeing them which is amazing. It’s great. You
don’t have to go through everything because they’ve found that information out previously. They’ve
absorbed it, they’re ready for it, so that means they’re ready for the next lot of information that they
need through their radiotherapy.”
Supportive Care Clinician 5
4. Discussion
This is the first study to: (i) investigate the feasibility of delivering an evidence-based
model of nutrition care for patients with HNC utilising supportive care and e-health technology
interventions and; (ii) explore the subsequent impact of the new model of care at individual, team and
system levels. The key interventions supported by multicomponent implementation strategies resulted
in improvements in adherence to EBG recommendations for nutrition care. This directly contributed to
clinically relevant reductions in critical weight loss, greater treatment completion rates and economically
pertinent decreases in unplanned admissions and lower costs of care. Although this study was not
powered to detect a statistically significant different in weight as a secondary outcome, these remain
promising findings, particularly given the higher prevalence of malnutrition at baseline in the
post-implementation cohort.
The findings highlight that, with a coordinated approach and adequate support, practice change
in alignment with the best available evidence is possible. This holds important implications
for health services aiming to deliver high-value care to complex patients with HNC. Although
it has been recognised that the evidence base to support decision making regarding optimal
guideline implementation strategies is imperfect [40], tailored interventions and adequate support are
acknowledged to be key to successful guideline implementation [41]. Our study corroborates findings
of other investigators who also found that dietitian-led behavior change intervention improved uptake
of nutrition care guidelines in patients with HNC [26].
A review of guideline implementation strategies found a 10% absolute improvement in the
desired direction of practitioner behavior change [42], whereas our study demonstrated an absolute
increase in adherence to nutrition care process recommendations for: malnutrition screening with
a validated tool (74%) and; nutrition assessment with a validated tool (15% at initial assessment,
76% during radiotherapy, 48% post-radiotherapy). In terms of adherence to the Dietitian Appointment
Schedule, the greatest improvement was seen in early access to care with the introduction of the
targeted intervention in the form of the Supportive Care-Led Pre-Treatment clinic (20% versus 97%).
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This may represent an increase in the on-treatment clinic capacity with resource-intensive initial
consultations, particularly for patients requiring education and counselling regarding feeding tubes,
allocated to a dedicated pre-treatment assessment. The absence of improvement in access to dietetic
care post-treatment is likely attributable to clinic demand exceeding capacity and thus a system and
resourcing issue, findings that are corroborated by McCarter et al. (2018). Based on the pilot results,
we hypothesize that were similar targeted interventions to be applied elsewhere in the patient care
pathway, greater guideline uptake and further improvements in outcomes may be observed.
To our knowledge, this is the first study to test the implementation of a Nutrition Care Dashboard
as a decision support tool for MDTs in patients with head and neck cancer. Health care dashboards are
gaining recognition in their ability provide streamlined data collection and user-friendly visualization
to quickly and efficiently guide clinical decision making [43]. Key elements of quality decision-making
tools include that they provide ready access to timely, relevant and reliable data that incorporate trends
or benchmarks [44]. Strategies for automation of the dashboard through creation of extractable data
fields in the eMR have laid the foundation for future sustainability of this tool for use within the MDT.
Our study demonstrated strong support for continuation of the dashboard at the team level due to
the enhanced communication and ability to flag the need for a coordinated MDT response to the
deteriorating patient.
The United Kingdom’s National Institute for Clinical Excellence [45] published guidance regarding
structure of services required to deliver care to complex patients with HNC highlights the importance
of expert dietitians as core members of the MDT [7,8]. Despite this, adequate dietetic resourcing
to deliver best practice nutrition care in cancer services is frequently met with financial constraints.
In our study, patients who received the new model of care experienced clinically relevant fewer
hospital admissions and those managed in the ambulatory setting used fewer dietetic resources
overall, providing support for a proactive approach to nutrition care. The new model of care resulted
in reduced costs of care equating to employing one full time equivalent (FTE) senior allied health
clinician per annum. In terms of sustainability, this justifies the investment required for continuing the
new model of care from an economic viewpoint. Additionally, the benefits to clinical outcomes and
improved access to care, care coordination and communication suggest an evidence-based model of
nutrition care can contribute to high-quality, high-value service delivery for these complex patients.
Another important element of sustainability for the new model of care identified in our study includes
leadership, both within dietetics and within the MDT more broadly. Greater awareness of the value of
cancer nutrition care amongst health service administrators and policy makers is also required in order
to optimized outcomes through research translation.
Staff and system domains should be considered as active components of the change process in
order to develop feasible and acceptable interventions in health care settings [46]. Clear support for
continuing the new model of care was evident at the team level from MDT member focus group data.
Improved care processes, workflow and time management, clinical leadership within the MDT, value
of nutrition care, integrated care coordination and communication and patients being prepared for
care were all identified as key elements or benefits of the new model of care. These data suggest that
the new model of care was considered by MDT members to be feasible, acceptable and appropriate.
This study has a number of strengths including the patient, caregiver and clinical team-centred
design of the new model of care, high fidelity to the intervention strategies and sound consultation
with and participation rates by the target groups. As this was a pilot study testing the feasibility
of delivering an evidence-based model of nutrition care, the authors acknowledge that participant
numbers are small. As a result, confirmation of these preliminary findings in a larger patient cohort is
warranted. The model of care could further be enhanced through exploration of service innovations that
reduce appointment burden and improve access to follow-up care in line with EBG recommendations,
particularly for long-distance patients [28]. Novel allied health-led telemedicine models of care have
demonstrated improved service efficiency and treatment satisfaction for patients with HNC [47,48]
and hold particular relevance in Australia and other countries with geographically vast services.
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Other study limitations include the inability to blind the MDT to the new model of care, which may
have influenced clinician motivation to adhere to the EBG recommendations. There were significant
organizational changes during the study period, although the research and clinical teams endeavored
to mitigate these challenges wherever possible.
5. Conclusions
This pilot study demonstrates that delivering a patient-centred, evidence-based model of nutrition
care in a major HNC centre is feasible and contributes to improved nutrition care processes and clinical
and cost outcomes. From an economic analysis point of view, the new model of care resulted in lower
costs of care. Benefits were also experienced by the clinical team through enhanced coordination,
communication and integration of care. These findings hold important implications for the provision
of evidence-based nutrition care to patients with HNC, suggesting that dietetic-led interventions can
deliver high-value care.
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